Two researchers from the University of New England in Armidale, Australia, have investigated the traditional medicines used in Australian Aboriginal cultures using gas chromatography- mass spectrometry (GC-MS) and gas chromatography with flame ionization detection (GC-FID).1
Two researchers from the University of New England in Armidale, Australia, have investigated thetraditional medicines used in Australian Aboriginal cultures using gas chromatography–mass spectrometry (GC–MS) and gas chromatography with flame ionization detection (GC–FID).1
Eremophilia longifolia is one of the most significant of the traditional medicines used by Aboriginalpeople. Its traditional use involves smoldering the leaves over hot embers and then either breathingin the smoke or bodily exposure to the fumes to provide relief for respiratory complaints.
Nicholas Sadgrove, an ethnobotanist and lead author of the study, became interested instudying this area of research after growing up surrounded by Aboriginal culture. Historically,Aboriginal medicine has been believed to be entirely ritualistic, with minimal proveneffects. However, there are many who believe that it may not be the medicinethat is limited, but the science itself. Sadgrove told The Column: “Our research isstarting to demonstrate that standard methods are failing to fully capturemedicinal effects described previously by Aboriginal people. Typically, when weinvestigate these things we’re looking for an ‘active’ principle, perhaps a molecule,that can adequately perform all of the medicinal effects described anecdotally.”
The team collected Eremophilia longifolia specimens from a range of locations in westernNew South Wales, Australia. Essential oils (both non-pyrolysed and partially pyrolysed) were extracted from the samplesusing hydrodistillation and part-wet/part-dry distillation. For identification and quantification of the essential oils, GC–MSand GC–FID were used. Analysis with GC–MS enabled confirmation of the essential oils but the pyrolysed fraction wasn’tvolatile at the lower temperatures used in GC. GC–FID was more useful because it enabled the amount of pyrolysedmaterial in the sample to be quantified, relative to the essential oil. Both non-pyrolysed and partially pyrolysed oils werefound to have approximately three or more times greater antimicrobial activity when warmed incrementally.
The team concluded that their results provide the first known Western scientific justification for the Aboriginal smokingceremonies. Sadgrove added: “We have recently begun similar experiments with other species used for ‘smokingceremonies’ in Australian ethnobotany. We are starting to get results that demonstrate a potential ‘active’ principle, possibly amolecule. With fractionation and purification, our ‘active’ molecule will most likely appear in GC–MS due to its low molecularsize. In this particular case, GC–MS will go a long way toward helping us to identify this molecule.”
Reference
1. 1. N.J. Sadgrove and G.L Jones, J Ethnopharmacol.147(3), 638–44 (2013).
This story originally appeared in The Column. Click here to view that issue.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.